Heart Failure Updates

Herausgeber: McMurray, John J. V.; Pfeffer, Marc

• Gebundenes Buch

Produktbeschreibung

Given the ever-advancing development of new pharmacological agents to treat heart conditions, clinicians could use a practical report on newly available treatments. The authors here address that need, profiling every pharmacological therapy in use to date for the treatment of heart failure. Renowned as experts in the field, these prominent academicians give incisive commentary on the state-of-the-art in heart failure, as their text is based on their personal experience with these drugs. Heart Failure Updates is a practical, information-packed reference that is essential for cardiologists, cardiac surgeons and associated specialists, particularly clinical biochemists, clinical pharmacologists, and epidemiologists.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: CRC Press
• Seitenzahl: 292
• Erscheinungstermin: 26. September 2003
• Englisch
• Abmessung: 240mm x 161mm x 20mm
• Gewicht: 605g
• ISBN-13: 9781841840727
• ISBN-10: 1841840726
• Artikelnr.: 21788924

Autorenporträt

John JV McMurray, MD, FRCP Professor of Medical Cardiology Honorary Consultant Cardiologist Western Infirmary And MRC Clinical Research Initiative in Heart Failure University of Glasgow Glasgow, UK Marc A Pfeffer, MD, PhD Cardiovascular Division Brigham and Women's Hospital Boston MA, USA

Inhaltsangabe

Anticytokine Therapy: What Went Wrong? Heart Failure Due to Diastolic
Dysfunction: Definition, Diagnosis and Treatment. Omaptrilat: The Potential
of Vasopeptidase Inhibition. Angiotensin Receptor Blockers: ELITE, ValHEFT
and Where Next? Atrial Fibrillation and Heart Failure: Etiological,
Prognostic and Therapeutic Considerations. Endothelin Receptor Antagonists:
Will They Join the Therapeutic Armamentarium? Betablockers: Mandatory for
All? Aldosterone Receptor Blockade: Is There an Opportunity for Further
Blockade in Patients with Heart Failure Treated with Standard Therapy
Including an ACE-Inhibitor and a Beta Adrenergic Blocking Agent? Nurse
Intervention: Can Our Patients Do Without It? Innovative Surgery: A New
Dawn in Heart Failure? The Era of Devices? Biventricular Pacing and ICDs.
New Treatments for Heart Failure: Successes and Failures. Metabolic
Co-morbid Conditions in Chronic Heart Failure: Diabetes and
Hypercholesterolemia. BNP: A Blood Test for the Diagnosis of Heart Failure
and Monitoring of Its Treatment?